Teva Pharmaceuticals has announced theintroduction and availability of Clopidogrel Tablets, an AB rated andbioequivalent product to Plavix Tablets (Bristol-Myers Squibb and SanofiAventis). Clopidogrel ...
Clopidogrel is prescribed to help prevent cardiovascular events such as heart attack and stroke in certain adults. It’s a generic medication that's available as the brand-name drug Plavix. The drug ...
As with other drugs, clopidogrel can cause side effects, such as bruising and bleeding. If you are not able to tolerate side effects from clopidogrel, talk with your doctor or pharmacist. Clopidogrel ...
BRIDGEWATER and PRINCETON, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Sanofi-aventis and Bristol-Myers Squibb Company announced today that the U.S. Food and Drug ...
Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Clopidogrel Tablets USP 75mg, which is being launched. Clopidogrel Tablets USP ...
For the second time in the past six months, a cardiology mainstay drug has lost patent protection and gone generic. Today the FDA announced that it had approved several generic versions of clopidogrel ...
Bridgewater/Princeton, NJ-The US FDA has approved a new 300-mg tablet of clopidogrel (Plavix, Sanofi-Aventis/Bristol-Myers Squibb) for use as a loading dose in acute ...
A single lot of 75-mg clopidogrel tablets that was distributed nationwide is being recalled by the manufacturer due to mislabeling. International Laboratories, LLC voluntarily initiated the recall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results